Market Cap 653.35B
Revenue (ttm) 94.19B
Net Income (ttm) 26.80B
EPS (ttm) N/A
PE Ratio 24.16
Forward PE 22.60
Profit Margin 28.46%
Debt to Equity Ratio 0.44
Volume 7,728,500
Avg Vol 8,162,900
Day's Range N/A - N/A
Shares Out 2.41B
Stochastic %K 86%
Beta 0.24
Analysts Strong Sell
Price Target $275.42

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospit...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 732 524 0400
Website: www.jnj.com
Address:
One Johnson & Johnson Plaza, New Brunswick, United States
JJBurch
JJBurch Aug. 20 at 2:03 PM
$TRUG MAJOR MOVE IMMINENT. CONFIRMATION! LEVELS SHOW MARKET MAKERS WITH BUYERS MOVING IN SETTING UP EASY TO SEE IN MICRO CAPS HIGHLY UNDERVALUED AND THE BREAKOUT IS NOW HERE. MOMENTS AWAY WATCH IT WATCH IT $MRNA $JNJ $TSLA
0 · Reply
HydrogenH2
HydrogenH2 Aug. 20 at 1:31 PM
$JNJ Wake me up under $250 !!
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Aug. 20 at 12:30 PM
$SLS $BMY $JNJ $BMY and $JNJ have been my Top 2 suitors for $SLS $BMY Billion Dollar Blockbuster Ventoclax will become Obsolete after GPS Approval. $BMY makes a move for Sellas GPS can not only protect Ventoclax but Maintenance Combo in 20+ WT1 cancers can Top Merck’s Keytruda Revenues of $31 Billion Annually. $JNJ is already on the table courting Sellas. Sellas Executive team quiet period on all clinical and corporate front points to an outright BO deal in works. Stay Tuned things will move quickly here. Moderna data yesterday is about to awake the cancer KRAKEN. ✌️🙏❤️‍🩹
0 · Reply
ForwardCurveCapital
ForwardCurveCapital Aug. 20 at 12:05 PM
$JNJ 📊 GlobalUSAEuity ▲ 273.41 (+0.85%) Trend: Strong Uptrend 🚀 RSI (14): 79.15 (Overbought ⚠️) MACD: Bullish, above signal line and rising 🟢 Volume: Normal ➖ 📌 Key Levels Resistance: 276.47 Support: 250.44 20-MA: 261.4 | 50-MA: 253.59 Educational content only. Not financial advice.
0 · Reply
JuggernautRaider
JuggernautRaider Aug. 20 at 11:37 AM
$BMY looking strong as a NJ pharma bond $PFE $NVS $JNJ too!!! 💫
0 · Reply
Flatflounder7
Flatflounder7 Aug. 20 at 11:28 AM
$AI $DGXX $EOSE $JNJ Digi ain’t spec, that mf is delivering
0 · Reply
aaa1233
aaa1233 Aug. 20 at 11:23 AM
When a company the size of $JNJ publicly states AML still needs longer-lasting remissions, more effective options after relapse, subtype-specific treatments, and better tolerated approaches for older patients, it reinforces how much unmet need remains in AML. Those are the exact problems GPS and SLS009 are being developed to address. $SLS https://www.jnj.com/health-and-wellness/what-is-acute-myeloid-leukemia
1 · Reply
StockBraker
StockBraker Aug. 20 at 11:21 AM
$JNJ https://www.investor.jnj.com/pipeline/development-pipeline/default.aspx
0 · Reply
Imr77
Imr77 Aug. 20 at 11:01 AM
$SLS well $MRK seems like $JNJ stole the trump card
0 · Reply
TeresaLey863
TeresaLey863 Aug. 20 at 7:27 AM
$V $JNJ $MA $INTC $ABBV Visa and Mastercard benefit from electronic-payment growth, Johnson & Johnson provides diversified healthcare exposure, Intel remains focused on semiconductor manufacturing and AI opportunities, and AbbVie benefits from its pharmaceutical portfolio. I'm watching payment volumes, healthcare demand, foundry execution, and prescription growth.
0 · Reply
Latest News on JNJ
Johnson & Johnson Transcript: Investor update

Aug 3, 2026, 8:00 AM EDT - 17 days ago

Johnson & Johnson Transcript: Investor update


Inside J&J's Lab to Create a Simpler Robotic Surgery Device

Aug 2, 2026, 8:00 AM EDT - 18 days ago

Inside J&J's Lab to Create a Simpler Robotic Surgery Device


Johnson & Johnson lowers 2026 profit forecast

Jul 29, 2026, 5:38 PM EDT - 21 days ago

Johnson & Johnson lowers 2026 profit forecast


Explainer: Can J&J finally put the talc litigation behind it?

Jul 29, 2026, 12:01 PM EDT - 21 days ago

Explainer: Can J&J finally put the talc litigation behind it?


Johnson & Johnson agrees to pay $5.5B to settle talc lawsuits

Jul 28, 2026, 12:26 PM EDT - 22 days ago

Johnson & Johnson agrees to pay $5.5B to settle talc lawsuits


J&J offers $5.5bn to settle baby powder lawsuits

Jul 28, 2026, 12:31 AM EDT - 23 days ago

J&J offers $5.5bn to settle baby powder lawsuits


DePuy Synthes Acquires Expanding Innovations™

Jul 16, 2026, 8:00 AM EDT - 5 weeks ago

DePuy Synthes Acquires Expanding Innovations™


Johnson & Johnson Earnings Call Transcript: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 5 weeks ago

Johnson & Johnson Earnings Call Transcript: Q2 2026


Johnson & Johnson Slides: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 5 weeks ago

Johnson & Johnson Slides: Q2 2026


Johnson & Johnson Earnings release: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 5 weeks ago

Johnson & Johnson Earnings release: Q2 2026


Johnson & Johnson Quarterly report: Q2 2026

Jul 15, 2026, 8:30 AM EDT - 5 weeks ago

Johnson & Johnson Quarterly report: Q2 2026


Johnson & Johnson Hikes Guidance, Stock Falls

Jul 15, 2026, 6:35 AM EDT - 5 weeks ago

Johnson & Johnson Hikes Guidance, Stock Falls


Johnson & Johnson Bumps Up Guidance as Sales Rise

Jul 15, 2026, 6:33 AM EDT - 5 weeks ago

Johnson & Johnson Bumps Up Guidance as Sales Rise


Johnson & Johnson reports Q2 2026 results, raises 2026 outlook

Jul 15, 2026, 6:20 AM EDT - 5 weeks ago

Johnson & Johnson reports Q2 2026 results, raises 2026 outlook


The Big 3: UNH, KO, JNJ

Jul 9, 2026, 1:00 PM EDT - 5 weeks ago

The Big 3: UNH, KO, JNJ

KO UNH


Johnson & Johnson to Buy Firefly Bio for $1 Billion

Jun 8, 2026, 9:01 AM EDT - 2 months ago

Johnson & Johnson to Buy Firefly Bio for $1 Billion


JJBurch
JJBurch Aug. 20 at 2:03 PM
$TRUG MAJOR MOVE IMMINENT. CONFIRMATION! LEVELS SHOW MARKET MAKERS WITH BUYERS MOVING IN SETTING UP EASY TO SEE IN MICRO CAPS HIGHLY UNDERVALUED AND THE BREAKOUT IS NOW HERE. MOMENTS AWAY WATCH IT WATCH IT $MRNA $JNJ $TSLA
0 · Reply
HydrogenH2
HydrogenH2 Aug. 20 at 1:31 PM
$JNJ Wake me up under $250 !!
0 · Reply
SellasgpsCurativeBAT11
SellasgpsCurativeBAT11 Aug. 20 at 12:30 PM
$SLS $BMY $JNJ $BMY and $JNJ have been my Top 2 suitors for $SLS $BMY Billion Dollar Blockbuster Ventoclax will become Obsolete after GPS Approval. $BMY makes a move for Sellas GPS can not only protect Ventoclax but Maintenance Combo in 20+ WT1 cancers can Top Merck’s Keytruda Revenues of $31 Billion Annually. $JNJ is already on the table courting Sellas. Sellas Executive team quiet period on all clinical and corporate front points to an outright BO deal in works. Stay Tuned things will move quickly here. Moderna data yesterday is about to awake the cancer KRAKEN. ✌️🙏❤️‍🩹
0 · Reply
ForwardCurveCapital
ForwardCurveCapital Aug. 20 at 12:05 PM
$JNJ 📊 GlobalUSAEuity ▲ 273.41 (+0.85%) Trend: Strong Uptrend 🚀 RSI (14): 79.15 (Overbought ⚠️) MACD: Bullish, above signal line and rising 🟢 Volume: Normal ➖ 📌 Key Levels Resistance: 276.47 Support: 250.44 20-MA: 261.4 | 50-MA: 253.59 Educational content only. Not financial advice.
0 · Reply
JuggernautRaider
JuggernautRaider Aug. 20 at 11:37 AM
$BMY looking strong as a NJ pharma bond $PFE $NVS $JNJ too!!! 💫
0 · Reply
Flatflounder7
Flatflounder7 Aug. 20 at 11:28 AM
$AI $DGXX $EOSE $JNJ Digi ain’t spec, that mf is delivering
0 · Reply
aaa1233
aaa1233 Aug. 20 at 11:23 AM
When a company the size of $JNJ publicly states AML still needs longer-lasting remissions, more effective options after relapse, subtype-specific treatments, and better tolerated approaches for older patients, it reinforces how much unmet need remains in AML. Those are the exact problems GPS and SLS009 are being developed to address. $SLS https://www.jnj.com/health-and-wellness/what-is-acute-myeloid-leukemia
1 · Reply
StockBraker
StockBraker Aug. 20 at 11:21 AM
$JNJ https://www.investor.jnj.com/pipeline/development-pipeline/default.aspx
0 · Reply
Imr77
Imr77 Aug. 20 at 11:01 AM
$SLS well $MRK seems like $JNJ stole the trump card
0 · Reply
TeresaLey863
TeresaLey863 Aug. 20 at 7:27 AM
$V $JNJ $MA $INTC $ABBV Visa and Mastercard benefit from electronic-payment growth, Johnson & Johnson provides diversified healthcare exposure, Intel remains focused on semiconductor manufacturing and AI opportunities, and AbbVie benefits from its pharmaceutical portfolio. I'm watching payment volumes, healthcare demand, foundry execution, and prescription growth.
0 · Reply
KathiDavis693
KathiDavis693 Aug. 20 at 7:06 AM
$DGXX $AI $EOSE $JNJ DGXX remains highly speculative, C3.ai remains focused on enterprise AI adoption, Eos Energy advances long-duration battery storage, and Johnson & Johnson provides diversified healthcare exposure. I'm watching funding, AI contracts, storage deployments, clinical catalysts, and healthcare demand.
0 · Reply
SniperAlphaCom
SniperAlphaCom Aug. 20 at 2:45 AM
$JNJ TS Update #3. Another higher high, another adjustment to the trailing stop. The position remains active and the stop now moves up with the structure — not the noise. From breakout → TS #1 → TS #2 → TS #3. Let the trend work until price says otherwise.
0 · Reply
Secretweapon
Secretweapon Aug. 19 at 11:28 PM
$JNJ buying moderna? BUYOUT
0 · Reply
Orchard
Orchard Aug. 19 at 11:16 PM
$JNJ $MRNA $LLY $PFE So JNJ couldn’t make sunscreen that didn’t cause cancer, and we now have a “cure for cancer” made with the same tech that caused my friend to go blind in his right eye from a $MRNA spike protein gene therapy with no long term testing…
0 · Reply
Investor203
Investor203 Aug. 19 at 10:37 PM
$MRNA or $JNJ will BO $VNDA
0 · Reply
Ryuk
Ryuk Aug. 19 at 7:57 PM
$JNJ Weak close. Puts almost near doubled off the lows. I’ll take it. Bears are in control now.
0 · Reply
Outcomes
Outcomes Aug. 19 at 7:14 PM
$IBRX $MRNA $PFE $JNJ ….‘lying through his teeth’ And now, immunocompromise, ‘turbo-cancers’ etc. etc. etc. Hey, BTW have you seen all those videos of elite athletes falling over?? 🙏🏻🙏🏻
2 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Aug. 19 at 6:44 PM
$JNJ no you didn’t, you’ve never owned any of them. Don’t lie you loser, just shut up and go away.
0 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Aug. 19 at 6:09 PM
$JNJ Nailed it!!! Any other predictions professor?
1 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Aug. 19 at 6:07 PM
$JNJ Bearish on everything except renewable energy? How’s that working out for you? $JNJ up 32% this year and 54% on the calendar year. Keep crushing it my guy!!!
1 · Reply
HydrogenH2
HydrogenH2 Aug. 19 at 5:34 PM
$JNJ But JNJ will need to pay down that $5B baby powder mess eventually... and some meds are going generics.. So a lot of goodies are "priced in already !!
0 · Reply
Ryuk
Ryuk Aug. 19 at 4:32 PM
$JNJ Red by close. Trash. 💩
0 · Reply